Literature DB >> 58257

Evaluation of three thyroid-function screening tests for detecting neonatal hypothyroidism.

P G Walfish.   

Abstract

Three thyroid-function detection methods were evaluated concomitantly for possible application as routine screening tests for the early diagnosis of neonatal hypothyroidism. Dried capillary-blood thyroxine (T4) was measured on eluted filter-paper discs for 9734 3-5-day old neonates. Serum T4 and thyroid-stimulating hormone (T.S.H.) assays from cord blood were studied as alternative screening tests on 4911 and 3733 infants, respectively. To avoid false-negative results, neonatal blood-T4 and cord serum-T4 screening methods were followed up for the lower 10th and 6th percentile, respectively. This resulted in a false-positive recall incidence greater than 92% owing to various additional factors which also influence T4 levels: thyroxine-binding-globulin deficiency, prematurity, and maternal drug ingestion. In marked contrast, cord T.S.H. as an initial screening test had a higher specificity and sensitivity for the diagnosis of primary hypothyroidism with the two affected cases, having values greater than 70 muU/ml (with only 0-24% of the screened population having values greater than 50 muU/ml). In order to avoid the impracticably high recallrate and false-positive incidence resulting from an initial T4 screening test, and to reduce the estimated follow-up recall to less than 0-2% of the screened infant population, it is recommended that infants with low T4 be selected for a supplementary T.S.H. screening test.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 58257     DOI: 10.1016/s0140-6736(76)92159-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  15 in total

1.  The periodic health examination. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  Can Med Assoc J       Date:  1979-11-03       Impact factor: 8.262

2.  Cord blood reverse T3 in normal, premature, euthyroid low T4, and hypothyroid newborns.

Authors:  J Ginsberg; P G Walfish; I J Chopra
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

3.  Down's syndrome and hypothyroidism.

Authors:  M W Quinn
Journal:  Ir J Med Sci       Date:  1980-01       Impact factor: 1.568

4.  Neonatal screening for hypothyroidism in Greece.

Authors:  C Mengreli; K Kassiou; S Tsagaraki; S Pantelakis
Journal:  Eur J Pediatr       Date:  1981-10       Impact factor: 3.183

5.  Congenital hypothyroidism. Clinical and laboratory characteristics in infants detected by neonatal screening.

Authors:  D A Price; R M Ehrlich; P G Walfish
Journal:  Arch Dis Child       Date:  1981-11       Impact factor: 3.791

6.  Screening for congenital hypothyroidism.

Authors: 
Journal:  Br Med J       Date:  1980-07-05

7.  Results of a regional cord blood screening programme for detecting neonatal hypothyroidism.

Authors:  P G Walfish; J Ginsberg; R A Rosenberg; N J Howard
Journal:  Arch Dis Child       Date:  1979-03       Impact factor: 3.791

8.  Newborn Screening Guidelines for Congenital Hypothyroidism in India: Recommendations of the Indian Society for Pediatric and Adolescent Endocrinology (ISPAE) - Part I: Screening and Confirmation of Diagnosis.

Authors:  M P Desai; R Sharma; I Riaz; S Sudhanshu; R Parikh; V Bhatia
Journal:  Indian J Pediatr       Date:  2018-01-30       Impact factor: 1.967

9.  Frequency of transient hypothyroxinaemia in low birthweight infants. Potential pitfall for neonatal screening programmes.

Authors:  S Uhrmann; K H Marks; M J Maisels; H E Kulin; M Kaplan; R Utiger
Journal:  Arch Dis Child       Date:  1981-03       Impact factor: 3.791

10.  Comparative evaluation of newborn bloodspot specimen cards by experienced laboratory personnel and by an optical scanning instrument.

Authors:  Paul D Dantonio; Germaine Stevens; Arthur Hagar; David Ludvigson; Daron Green; Harry Hannon; Robert F Vogt
Journal:  Mol Genet Metab       Date:  2014-07-18       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.